Utilizing DreaMed Diabetes’s Advisor Pro software, the prestigious health system will onboard 100 people with diabetes to assess the workflow, satisfaction, and financial aspects of an AI-based decision support system in a protocol that allows for both virtual and in-person visits. Read...
Read MoreVANCOUVER, British Columbia & SURREY, England–(BUSINESS WIRE)– Biotech company SaNOtize Research & Development Corp., (SaNOtize), Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, and Berkshire and Surrey Pathology Services, UK, today announced results of clinical trials indicating that SaNOtize’s Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected. Read more...
Read MoreVANCOUVER — A B.C. biotech firm says it has developed an effective treatment for anyone who’s contracted COVID-19, and is now seeking federal approval for emergency use of the product. Following months of clinical trials, Vancouver-based SaNOtize says its nasal spray has been found to reduce COVID-19 levels by 95 per cent within 24 hours, and more than 99 per cent in under three days. Watch...
Read MoreThe drugmaker has completed a Phase 2 clinical trial in the UK, Israeli CEO says treatment can help vaccines defeat the pandemic. Read more...
Read More
Startup of the Week: Nexa3D enters Formula 1 BrainQ trial offers new hope for stroke victims Hasanat Dewan joins OurCrowd as Chief Innovation Officer Customers flock to ByondXR’s pop-up stores for Lancôme H2Pro: Gates-backed startup joins race to make green hydrogen TytoCare adds $50 million D-ID: From MyHeritage to rich content advertising and film Pop-up antennas slash price of satellite communications Online pharmacy Ro vaccinates seniors at home HIL-CERN collaboration to develop proton therapy for cancer Introductions 1,000 high-tech jobs Startup of the Week:Formula 1 selects Nexa3D’s high-speed 3D printing Williams Racing, the 16-time Formula 1 champion, has selected Nexa3D’s NXE400 ultrafast photoplastic 3D printer to create components for wind tunnels used to test cars and components, reducing manufacturing time from hours to minutes, TCT Magazine reports. “The NXE400 breaks printing speed barriers with its 20X productivity,” Williams said in a statement. “Formula One is a challenging environment that demands a continuous improvement philosophy in order to remain competitive. Our partnership will enable the team to continue to push boundaries in 3D printing, and present new opportunities for Nexa3D...
Read More
